Company intelligence / Profile preview

Savant HWP, Inc.

San Carlos, California, United Statescrunchbase.com ↗

Ownership: Private
Employees: ~5
Development stage: Phase 1

Overview

Savant HWP developed 18-MC, a novel anti-addiction compound targeting the dopamine reward pathway. Early human safety trials showed good tolerability. The company also pursued treatments for leishmaniasis and Chagas disease. As of recent years, its assets—including the lead program—were acquired by MindMed.

Therapeutic areas: PsychiatryEndocrinologyInfectious Diseases
Modalities: Small molecules (notably 18-MC and related synthetic organic compounds)
Industry: Biotech

Drug pipeline

2 assets

18-MC

Phase 1

Indications: Opioid withdrawal, Opioid use disorder, Substance use disorders

1 more asset in the full pipeline.

Request access →

Partnerships

Partnered with a South American organization for early-stage human safety studies on leishmaniasis treatment using their compounds.Collaboration history with InHale Therapeutics.

Beyond the preview

Go deeper on Savant HWP, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Savant HWP, Inc..

Explore the full profile